Compare Lustrum:JCR Pharmaceuticals Co.,Ltd.:4552

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index JCR Pharmaceuticals Co.,Ltd. Go to web site 4552 Medicals 東証プライム March 1, 2000 1992.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

JCR Pharmaceuticals Co.,Ltd. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

JCR Pharmaceuticals Co.,Ltd. Balance Sheet 2025年3月期 JCR Pharmaceuticals Co.,Ltd. Balance Sheet 2024年3月期 JCR Pharmaceuticals Co.,Ltd. Balance Sheet 2023年3月期 JCR Pharmaceuticals Co.,Ltd. Balance Sheet 2022年3月期 JCR Pharmaceuticals Co.,Ltd. Balance Sheet 2021年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2025 March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021
Cash and Cash Equivalents
(Percent)
13,196down
(12.6%)down
18,756up
(18.3%)up
13,278down
(14.0%)down
30,733up
(31.6%)down
26,260
(35.6%)
Other Current AssetsHelp
(Percent)
37,860down
(36.1%)down
38,825up
(38.0%)up
34,524up
(36.4%)up
31,455up
(32.4%)up
22,285
(30.2%)
Tangible Fixed AssetsHelp
(Percent)
37,410up
(35.7%)up
30,040down
(29.4%)down
32,681up
(34.4%)up
26,782up
(27.6%)up
17,172
(23.3%)
Intangible Fixed AssetHelp
(Percent)
2,960down
(2.8%)down
3,496down
(3.4%)down
3,652up
(3.8%)up
2,960down
(3.0%)down
3,232
(4.4%)
Investments and OthersHelp
(Percent)
13,429up
(12.8%)up
11,109up
(10.9%)down
10,802up
(11.4%)up
5,204up
(5.4%)down
4,835
(6.6%)
Total AssetsHelp
(Percent)
104,855
(100%)
102,226
(100%)
94,937
(100%)
97,134
(100%)
73,784
(100%)
Total Current LiabilitiesHelp
(Percent)
45,764up
(43.6%)up
31,698down
(31.0%)down
37,275down
(39.3%)down
43,300up
(44.6%)up
30,151
(40.9%)
Total Long-term LiabilitiesHelp
(Percent)
12,050down
(11.5%)down
14,350up
(14.0%)up
5,500up
(5.8%)up
2,950down
(3.0%)down
5,250
(7.1%)
Shareholder's EquityHelp
(Percent)
47,041down
(44.9%)down
56,178up
(55.0%)up
52,162up
(54.9%)up
50,884up
(52.4%)up
38,383
(52.0%)
Total LiabilitiesHelp
(Percent)
104,855
(100%)
102,226
(100%)
94,937
(100%)
97,134
(100%)
73,784
(100%)

JCR Pharmaceuticals Co.,Ltd. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

JCR Pharmaceuticals Co.,Ltd. Profit and Loss Account 2025年3月期 JCR Pharmaceuticals Co.,Ltd. Profit and Loss Account 2024年3月期 JCR Pharmaceuticals Co.,Ltd. Profit and Loss Account 2023年3月期 JCR Pharmaceuticals Co.,Ltd. Profit and Loss Account 2022年3月期 JCR Pharmaceuticals Co.,Ltd. Profit and Loss Account 2021年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2025 March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021
Amount of Sales
(Percent)
33,072
(100%)
42,871
(100%)
34,343
(100%)
51,082
(100%)
30,085
(100%)
Total Sales
(Percent)
33,072
(100%)
42,871
(100%)
34,343
(100%)
51,082
(100%)
30,085
(100%)
Cost of SalesHelp
(Percent)
11,333down
(34.3%)up
11,620up
(27.1%)up
8,886down
(25.9%)up
10,461up
(20.5%)down
7,812
(26.0%)
Other Costs and RevenueHelp 26,498up
(80.1%)up
25,742up
(60.0%)down
21,684down
(63.1%)up
26,113up
(51.1%)down
15,380
(51.1%)
Total CostsHelp 37,831 37,362 30,570 36,574 23,192
Net RevenueHelp 21,739down
(65.7%)down
31,251up
(72.9%)down
25,457down
(74.1%)down
40,621up
(79.5%)up
22,273
(74.0%)
Earnings Before TaxHelp -6,414down
(-19.4%)down
7,244up
(16.9%)up
5,412down
(15.8%)down
19,404up
(38.0%)up
8,653
(28.8%)
Net IncomeHelp -4,759down
(-14.4%)down
5,509up
(12.9%)up
3,773down
(11.0%)down
14,508up
(28.4%)up
6,893
(22.9%)
当期純利益 -4,759 5,509 3,773 14,508 6,893

JCR Pharmaceuticals Co.,Ltd. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

JCR Pharmaceuticals Co.,Ltd. Cash Flow Statement 2025年3月期 JCR Pharmaceuticals Co.,Ltd. Cash Flow Statement 2024年3月期 JCR Pharmaceuticals Co.,Ltd. Cash Flow Statement 2023年3月期 JCR Pharmaceuticals Co.,Ltd. Cash Flow Statement 2022年3月期 JCR Pharmaceuticals Co.,Ltd. Cash Flow Statement 2021年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2025 March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021
Operating Cash Flow(OFC)Help
(Percent)
-5,485down
(-35.7%)down
9,312up
(91.3%)up
-5,499down
(-26.8%)down
9,289down
(93.8%)up
10,340
(55.5%)
Investing Cash Flow(ICF)Help
(Percent)
-9,874down
(-64.3%)down
-2,690up
(-26.4%)up
-15,002down
(-73.2%)down
-3,250up
(-32.8%)down
-3,290
(-17.6%)
Financing Cash FlowHelp
(Percent)
9,736up
(63.4%)up
-2,031down
(-19.9%)down
1,948up
(9.5%)up
-2,179down
(-22.0%)down
8,304
(44.5%)
Exchange Difference of Cash and Cash EquivalentsHelp
(Percent)
64down
(0.4%)down
886down
(8.7%)up
1,099up
(5.4%)down
612up
(6.2%)up
-22
(-0.1%)
Net Increase and Decrease in Cash and Cash Equivalentsn -5,559down
(-36.2%)down
5,477up
(53.7%)up
-17,454down
(-85.1%)down
4,472down
(45.2%)down
15,332
(82.2%)

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

JCR Pharmaceuticals Co.,Ltd.
BrightPath Biotherapeutics Co., Ltd.
TERASAKI ELECTRIC CO.,LTD.

Company where related level is highHelp

Nichi-Iko Pharmaceutical Co.,Ltd.
TOWA PHARMACEUTICAL CO.,LTD.
ONO PHARMACEUTICAL CO.,LTD.
NANO MRNA Co., Ltd.
Mitsubishi Tanabe Pharma Corporation
ZERIA PHARMACEUTICAL CO.,LTD.
D.Western Therapeutics Institute, Inc.
WAKAMOTO PHARMACEUTICAL CO.,LTD.
SSP CO.,LTD.
NIPPON CHEMIPHAR CO.,LTD.